Cargando…

Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study

BACKGROUND: Respiratory syncytial virus (RSV) infection poses a substantial clinical burden among infants and young children. We sought to determine the health care costs of hospitalizations attributable to RSV in Ontario, Canada, from the health care payer perspective. METHODS: For this population-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thampi, Nisha, Knight, Braden D., Thavorn, Kednapa, Webster, Richard J., Lanctot, Krista, Hawken, Steven, McNally, J. Dayre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526091/ https://www.ncbi.nlm.nih.gov/pubmed/34667075 http://dx.doi.org/10.9778/cmajo.20200219

Ejemplares similares

Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017
por: Kim, Doyoung, et al.
Publicado: (2019)

Extending the science fair project beyond the walls of the gymnasium with the Canadian Science Fair Journal
por: Ng, Rhiannon, et al.
Publicado: (2019)

Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations
por: Paes, B., et al.
Publicado: (2011)

Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33–35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study
por: Papenburg, Jesse, et al.
Publicado: (2020)

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada
por: Mitchell, Ian, et al.
Publicado: (2021)

First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
por: Wang, Daniel Y., et al.
Publicado: (2017)

Erratum to: Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations
por: Paes, B., et al.
Publicado: (2012)

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention
por: Chen, Jinghan Jenny, et al.
Publicado: (2015)

Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore
por: Tam, Clarence C., et al.
Publicado: (2020)

The association between climate, geography and respiratory syncitial virus hospitalizations among children in Ontario, Canada: a population-based study
por: Radhakrishnan, Dhenuka, et al.
Publicado: (2020)

COVID-19 Pandemic: Did Strict Mobility Restrictions Save Lives and Healthcare Costs in Maharashtra, India?
por: Ambade, Preshit Nemdas, et al.
Publicado: (2023)

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2016)

Cost analysis of the very elderly admitted to intensive care units
por: Chin-Yee, Nicolas, et al.
Publicado: (2017)

862. Impact of Caregiver Health on Pediatric Healthcare-Associated Viral Respiratory Infections (HAVRIs): A Retrospective Study
por: Paquette, Maude, et al.
Publicado: (2020)

Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
por: Nithianandan, Harrish, et al.
Publicado: (2019)

Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study
por: Lee, Justin, et al.
Publicado: (2021)

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
por: Paes, B., et al.
Publicado: (2012)

Primary Bankart Repair Versus Arthroscopic Anatomic Glenoid Reconstruction in Patients with Subcritical Bone Loss: A Cost-Utility Analysis
por: Ali, Zakariya S., et al.
Publicado: (2021)

Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost
por: Bozzola, Elena, et al.
Publicado: (2021)

1711. Prospective Environmental Surveillance of Floors in a Pediatric Emergency Department During a Respiratory Syncytial Virus Surge in Ottawa, Canada
por: Thampi, Nisha, et al.
Publicado: (2023)

Factors contributing to high-cost hospital care for patients with COPD
por: Mulpuru, Sunita, et al.
Publicado: (2017)

The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada
por: Black, Cody D., et al.
Publicado: (2019)

Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
por: Kimpton, Miriam, et al.
Publicado: (2021)

Modelling the Seasonal Epidemics of Respiratory Syncytial Virus in Young Children
por: Moore, Hannah C., et al.
Publicado: (2014)

Human respiratory syncytial virus and hospitalization in young children in Italy
por: Kuhdari, Parvanè, et al.
Publicado: (2018)

Abstract 16: The Use of Paravertebral Nerve Blocks in Immediate Breast Reconstruction following Mastectomy: A Canadian Hospital-Perspective Cost Effectiveness Analysis
por: Stein, Michael J., et al.
Publicado: (2018)

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
por: Johnson, Sara M., et al.
Publicado: (2015)

Maternal Vitamin D Status and Gestational Weight Gain as Correlates of Neonatal Bone Mass in Healthy Term Breastfed Young Infants from Montreal, Canada
por: Gharibeh, Nathalie, et al.
Publicado: (2021)

Health system costs of potentially inappropriate prescribing in Ontario, Canada: a protocol for a population-based cohort study
por: Black, Cody D, et al.
Publicado: (2018)

Dizziness at a Canadian tertiary care hospital: a cost-of-illness study
por: Le, Andre, et al.
Publicado: (2019)

Pro/Con debate: Are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?
por: Thampi, Nisha, et al.
Publicado: (2012)

Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting
por: Scarffe, Andrew D., et al.
Publicado: (2022)

Successful incorporation of single reviewer assessments during systematic review screening: development and validation of sensitivity and work-saved of an algorithm that considers exclusion criteria and count
por: Nama, Nassr, et al.
Publicado: (2021)

Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada
por: Mercier, Elisabeth, et al.
Publicado: (2023)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Assessing potentially inappropriate prescribing (PIP) and predicting patient outcomes in Ontario’s older population: a population-based cohort study applying subsets of the STOPP/START and Beers’ criteria in large health administrative databases
por: Bjerre, Lise M, et al.
Publicado: (2015)

Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand
por: Grant, Alyssa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vvsdfthsh12j53sqmu33q4ilt1